Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Paclitaxel is a potent anticancer agent originally derived from the bark of the Pacific yew tree, Taxus brevifolia, and is now produced through semi-synthetic methods due to its limited natural supply. It functions by stabilizing microtubules, thereby inhibiting cell division, which is crucial for its effectiveness against various cancers, including breast, lung, and ovarian cancers. The biosynthesis of paclitaxel involves complex pathways, and recent advances have focused on enhancing its bioavailability and developing novel formulations, such as nanoparticle polymeric micellar paclitaxel, to improve its therapeutic index and reduce side effects. Research continues to explore its applications and production methods to meet the growing demand for this essential medicine. Synonyms for paclitaxel include Taxol, Onxal, Anzatax, Asotax, Bristaxol, Praxel, Paxene, and Paclitaxel Injection.
仅用于科研。不用于诊断过程。未经明确授权不得转售。